Site Logo

Download QR

Open Free Demat Account!

Join Our 9 Lakh Customers

+91
Headphone

Home

Mutual Funds

Nippon India Pharma Fund

Ni

Nippon India Pharma Fund

Sectoral-PharmaRank #25
3/5

NAV (2026-07-14)

564.6

AUM

₹9,044.23 Cr

Exp. Ratio: 1.82%

RISK LEVEL

Very High

Returns & Performance

1 Year8.82%4.01% vs cat avgRank #24
3 Year20.30%2.32% vs cat avgRank #13
5 Year12.55%0.90% vs cat avgRank #9
Since Launch20.00%--

Fund vs Category Average

1Y
8.82%-4.01%
3Y
20.30%-2.32%
5Y
12.55%-0.90%

Pros & Cons

Pros

No lock-in period

Cons

1Y returns trail category average
3Y returns below category average
5Y returns below category average
Higher expense ratio (1.82%)
1Y category rank outside top 15 (#24)
Overall rank #25 in category
ISININF204K01968
NAV₹564.6
NAV Date2026-07-14
AUM₹9,044.23 Cr
Expense Ratio1.82%
RiskVery High
Rating3 / 5
Min SIP Amount₹100
Max SIP Amount₹999999999
Min Additional Inv.₹1000
SIP AllowedYes
Plan TypeRegular
Plan OptionGrowth
Is NFONo
Fund House Incorp.1995-06-30

INVESTMENT OBJECTIVE

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Exit Load1.00%
Stamp duty on investment0.005% (from July 1st, 2020)
Tax implicationsIf you redeem within one year, your returns will be taxed at 20%. For redemptions after one year, returns exceeding ₹1.25 lakh in a financial year will be taxed at 12.5%.

Amber Singhania

MMS Finance (Mumbai University)

Prior to joining the Nippon India AMC, he was associated with Asian Markets Securities Pvt. Ltd.

Top Holdings

Holdings data not available for this scheme